Updated: FDA approves Servier’s brain cancer drug, setting up $1B payout for Agios
The FDA approved a new treatment for a rare form of brain cancer whose tumors have a mutation that drives the disease.
Tuesday’s approval of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
